StephenFormanMD

City of Hope Professor, Hematology and Hematopoietic Cell Transplantation, Director, T Cell Therapeutics Research Laboratories, Director, Hematologic Malignancies Research Institute, Co-leader, Hematologic Malignancies Program, Professor, Medical Oncology & Therapeutics Research Francis and Kathleen McNamara Distinguished Chair in Hematology/Hematopoietic Cell Transplantation (1987-2019)

Join to view full profile

Dr. Forman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Forman's full profile

Already have an account?

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-359-8111

Fax+1 626-218-5310

Summary

I am a hematologist at City of Hope in Duarte, California. I am deeply involved with the translational and clinical research at City of Hope's Toni Stephenson Lymphoma Center, Judy and Bernard Briskin Center for Multiple Myeloma Research and Gehr Family Center for Leukemia Research.

My current projects are focused on immunotherapy — using the body's own immune system to attack cancer.

Education & Training

City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1980
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1978 - 1979
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1976 - 1978
Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 1975 - 1976
Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 1974 - 1975
Keck School of Medicine of the University of Southern CaliforniaClass of 1974

Certifications & Licensure

CA State Medical License 1975 - 2026
NC State Medical License 2021 - 2022
AZ State Medical License 1999 - 2008
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

E.Donnall Thomas Lecturer TCT/ASBMT, 2019
DKMS Mechtild Harf Science Award DKMS, 2019
Association of American Physicians Association of American Physicians, 2018
America's Top Doctors Castle Connolly, 2006-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Southern California Castle Connolly, 2012
Town & Country Magazine: Top Doctors Castle Connolly, 2000
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia Start of enrollment: 1995 Jul 01
Completed
Phase 2
Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
Completed
Not Applicable
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma Start of enrollment: 2002 Feb 01
Completed
Phase 1
Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Start of enrollment: 2008 Aug 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902) Start of enrollment: 2011 Jan 01
Completed
Not Applicable
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
COMPLETED
PHASE2
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen Start of enrollment: 2011 Nov 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma.
Hui-Ju Hsieh, Ryan Urak, Mary C Clark, Larry W Kwak, Stephen J Forman
Molecular Therapy. Methods & Clinical Development. 2025-03-13
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.
Kristy K Broman, Qingrui Meng, Anna Holmqvist, Nora Balas, Joshua Richman
JAMA Dermatology. 2025-03-01
1 citations
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impact...
Jose Tinajero, Sharon Xu, Dat Ngo, Shanpeng Li, Joycelynne Palmer
British Journal of Haematology. 2025-03-01

Journal Articles

Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2
Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature
Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia
Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature

Abstracts/Posters

Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Checkpoint Blockade in Combination with CD33 Chimeric Antigen Receptor T Cell Therapy and Hypomethylating Agent Against Acute Myeloid Leukemia
Stephen J Forman, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019
Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, a...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) _ a Report from the BMT Survivor St...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties
Stephen J. Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identif...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
PET-Adapted Nivolumab or Nivolumab Plus ICE As First Salvage Therapy in Relapsed or Refractory Hodgkin Lymphoma
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Dynamic Assembly of a Feedback Complex to Regulate Oncogenic B-Cell Receptor-Signaling
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Incidence and Risk Factors of De Novo Skin Cancer in a Contemporary Cohort of Hematopoietic Cell Transplantation Survivors
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Stroke Risk in Blood or Marrow Transplant (BMT) Survivors _ a Report from the BMT Survivor Study (BMTSS)
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma
Stephen J. Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single Center
Stephen J. Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
FLT3-ITD Activates Cytoplasmic Drosha-Dependent Non-Canonical Mechanisms of Mir-155 Biogenesis in Acute Myeloid Leukemia
Stephen J. Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Peri-Transplant Administration of Ruxolitinib Is Safe and Feasible in Patients with Myelofibrosis: Primary Results of a Pilot Open-Label Study of Ruxolitinib Administr...
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Longitudinal Trajectory of Frailty in Blood or Marrow Transplant (BMT) Survivors _ a BMT Survivor Study (BMTSS)
Stephen J Forman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

6th Annual Conference On How The Experts Treat Hematologic Malignancies
City of Hope, Santa Monica, California - 9/18/2013

Press Mentions

Remembering Our Renowned Virologist John ZaiaFebruary 13th, 2025
Local Companies and Research Institutes at Forefront of Cancer Immunotherapy DevelopmentMarch 13th, 2023
Why Unvaccinated People Are Being Denied Organ TransplantsOctober 20th, 2021
Join now to see all